T5000

USPTO USPTO 2006 CANCELLED - SECTION 8

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die US-Marke T5000 wurde als Wortmarke am 14.08.2006 beim Amerikanischen Patent- und Markenamt angemeldet.
Sie wurde am 04.05.2010 im Markenregister eingetragen. Der aktuelle Status der Marke ist "CANCELLED - SECTION 8".

Markendetails

Markenform Wortmarke
Aktenzeichen 78951840
Registernummer 3786332
Anmeldedatum 14. August 2006
Veröffentlichungsdatum 24. Juli 2007
Eintragungsdatum 04. Mai 2010

Markeninhaber

1896 RUTHERFORD ROAD
92008 CARLSBAD
US

Markenvertreter

Waren und Dienstleistungen

42 Scientific and technological research services in the areas of analysis of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens; identification of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens; development for others and leasing to others of biosensor systems for analysis of nucleic acid sequences, nucleic acids, genetic materials, infectious and/or pathogens, and parts therefor, for scientific and research use; development for others and leasing to others of biosensor systems for identification of nucleic acid sequences, nucleic acids, genetic materials, infectious and/or pathogens, and parts therefor, for scientific and research use; development for others and leasing to others of test and collection devices and kits for analysis of nucleic acid sequences, nucleic acids, genetic materials, infectious and/or pathogens for scientific and research use; development for others and leasing to others of test and collection devices and kits for identification of nucleic acid sequences, nucleic acids, genetic materials, infectious and/or pathogens for scientific and research use; development for others and leasing to others of computer software and hardware for analysis of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens; development for others and leasing to others of computer software and hardware for identification of nucleic acid sequences, nucleic acids, genetic materials, infectious agents and/or pathogens; development for others of biosensor systems for analysis of nucleic acid sequences, nucleic acids, genetic materials, infectious and/or pathogens, and parts therefor, for medical use; development for others of biosensor systems for identification of nucleic acid sequences, nucleic acids, genetic materials, infectious and/or pathogens, and parts therefor, for medical use; development for others of test and collection devices and kits for analysis of nucleic acid sequences, nucleic acids, genetic materials, infectious and/or pathogens for medical use; development for others of test and collection devices and kits for identification of nucleic acid sequences, nucleic acids, genetic materials, infectious and/or pathogens for medical use
44 Leasing to others of biosensor systems for analysis of nucleic acid sequences, nucleic acids, genetic materials, infectious and/or pathogens, and parts therefor, for medical use; leasing to others of biosensor systems for identification of nucleic acid sequences, nucleic acids, genetic materials, infectious and/or pathogens, and parts therefor, for medical use; leasing to others of test and collection devices and kits for analysis of nucleic acid sequences, nucleic acids, genetic materials, infectious and/or pathogens for medical use; leasing to others of test and collection devices and kits for identification of nucleic acid sequences, nucleic acids, genetic materials, infectious and/or pathogens for medical use
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

ID: 1378951840